To access this element change to forms mode OFF

Archived Grant Opportunity View - GO2511

Medical Research Future Fund - Accelerated Research - Congenital Heart Disease

Contact Details

13 28 46



Department of Health
Close Date & Time:
12-Sep-2019 5:00 pm (ACT Local Time)
Show close time for other time zones
Primary Category:
231005 - Cardiovascular Health
Secondary Category:
321003 - Scientific Research
Publish Date:
ACT, NSW, VIC, SA, WA, QLD, NT, TAS, Administered Territories
Selection Process:
Open Competitive


The Congenital Heart Disease (CHD) grant opportunity forms part of the Accelerated Research initiative, funded through the Medical Research Future Fund (MRFF).

The CHD grant opportunity supports research to provide new diagnoses and treatment options for those suffering from congenital heart disease.

For this grant opportunity $20 million is available over 5 years from 2019-20 to 2023-24.

  • There is no minimum grant amount.
  • The maximum grant amount is $10 million.
  • The grant amount will be up to 100 per cent of eligible project costs.
  • You must complete your project by 30 June 2024.

Ideally projects will align with  the National Strategic Action Plan for Childhood Heart Disease, and could target the Research Priorities in the Action Plan in particular:

  • preventing neurodevelopmental and mental health complications
  • understanding the impact of prenatal and postnatal factors affecting the health of children born with CHD and their families, or
  • exploring the role of exercise and increased activity in reducing the impact of CHD.

You must ensure new research is complementary to, and does not duplicate work in the following MRFF Accelerated Research Investments:

  • The Stem Cells Australia research study into development of human heart tissue for understanding heart disease, improving repair and reconstructing tissues for kids with heart defects.
  • The Murdoch Children’s Research Institute project to enable the Australian Genomics Health Alliance to extend the Cardiovascular Genetic Disorders Flagship study, which aims to interrogate the genomic basis of disease in individuals and families with cardiomyopathies, arrhythmias and congenital heart disease.

 To be eligible you must:

  • have an Australian Business Number (ABN)
  • be incorporated in Australia

and, in accordance with s24 of the Medical Research Future Fund Act 2015, you must be one of the following eligible bodies:

  • a medical research institute
  • a university
  • a corporate Commonwealth entity
  • a corporation (including businesses and not for profits).

Joint applications are encouraged, provided you have a lead applicant who is the main driver of the project and is eligible to apply. For further information on joint applications, refer to the grant opportunity guidelines.

You are not eligible to apply if you are:

  • an individual
  • partnership
  • trust (however, an incorporated trustee may apply on behalf of a trust)
  • a non-corporate Commonwealth entity.
Total Amount Available (AUD):


Instructions for Application Submission:
Other Instructions: provides information and advice to customers via a range of channels including phone (13 28 46), email and web chat. Contact us for assistance.

Contact Details

13 28 46